138 related articles for article (PubMed ID: 31244641)
1. Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report.
Toriu N; Sekine A; Mizuno H; Hasegawa E; Yamanouchi M; Hiramatsu R; Hayami N; Hoshino J; Kawada M; Suwabe T; Sumida K; Sawa N; Takaichi K; Ohashi K; Fujii T; Matoba S; Ubara Y
Case Rep Oncol; 2019; 12(2):391-400. PubMed ID: 31244641
[TBL] [Abstract][Full Text] [Related]
2. [A case of thrombotic microangiopathy with glomerular subendothelial IgA deposition due to bevacizumab].
Tomita M; Ochiai M; Shu S; Yamauchi Y; Shihara H; Ogata A; Fujisawa N; Yanai Y; Kamata T; Iehara N
Nihon Jinzo Gakkai Shi; 2014; 56(5):612-7. PubMed ID: 25130034
[TBL] [Abstract][Full Text] [Related]
3. Progressive bevacizumab-associated renal thrombotic microangiopathy.
Uy AL; Simper NB; Champeaux AL; Perkins RM
NDT Plus; 2009 Feb; 2(1):36-9. PubMed ID: 25949282
[TBL] [Abstract][Full Text] [Related]
4. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.
Morimoto M; Arai T; Matsuura M; Ono Y
CEN Case Rep; 2021 Feb; 10(1):6-11. PubMed ID: 32642991
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.
Yahata M; Nakaya I; Sakuma T; Sato H; Aoki S; Soma J
BMC Res Notes; 2013 Nov; 6():450. PubMed ID: 24207130
[TBL] [Abstract][Full Text] [Related]
7. Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer.
Yoshimura Y; Sawa N; Matsuoka S; Ikuma D; Oba Y; Sekine A; Hasegawa E; Mizuno H; Yamanouchi M; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Toda S; Matoba S; Wakui H; Ubara Y
Intern Med; 2022 Dec; 61(23):3547-3552. PubMed ID: 35569979
[TBL] [Abstract][Full Text] [Related]
8. Nintedanib-Induced Renal Thrombotic Microangiopathy.
Fujita T; Nakagawa H; Yokota T; Umetani J; Nagawa D; Nakata M; Narita-Kinjo I; Murakami R; Shimada M; Nakamura N; Tomita H
Case Rep Nephrol Dial; 2021; 11(2):227-232. PubMed ID: 34414215
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury.
Touzani F; Geers C; Pozdzik A
Case Rep Nephrol; 2019; 2019():2919080. PubMed ID: 31934470
[TBL] [Abstract][Full Text] [Related]
10. Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature.
Zhu W; Wang W; Shi Y; Shen B; Li Y
Virchows Arch; 2023 Oct; 483(4):561-567. PubMed ID: 37101053
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports.
Hsu PC; Chen TD; Tsai TY; Yang CT
Clin Pract; 2023 Jan; 13(1):200-205. PubMed ID: 36826160
[TBL] [Abstract][Full Text] [Related]
12. A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.
Masuzawa N; Nishimura A; Kitani T; Tamagaki K; Sugitani M; Nagoshi H; Kuroda J; Konishi E
Pathol Int; 2017 Dec; 67(12):620-625. PubMed ID: 28940837
[TBL] [Abstract][Full Text] [Related]
13. A patient with thrombotic microangiopathy accompanied by glomerular subendothelial electron dense deposits.
Kimura M; Fujigaki Y; Ohtake T; Furuya R; Hishida A; Kaneko E
Am J Nephrol; 1998; 18(2):155-9. PubMed ID: 9569960
[TBL] [Abstract][Full Text] [Related]
14. A case of ramucirumab-induced renal failure with nephrotic-range proteinuria and its pathological findings.
Nakano Y; Kumagai J; Nagahama K; Fujisawa H
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653851
[TBL] [Abstract][Full Text] [Related]
15. [A case of nephrotic syndrome during TS-1 therapy after resection of rectal cancer and liver metastasis].
Sakagashira M; Yamada Y
Nihon Jinzo Gakkai Shi; 2014; 56(4):538-44. PubMed ID: 24956887
[TBL] [Abstract][Full Text] [Related]
16. [Transplantation-associated thrombotic microangiopathy confirmed by renal biopsy].
Miyamoto S; Kimura S; Hosoya Y; Hasegawa D; Ishida H; Daida A; Matsui T; Yoshimoto Y; Hirabayashi S; Fujimaru T; Kumamoto T; Mori SI; Suzuki K; Manabe A
Rinsho Ketsueki; 2018; 59(4):389-394. PubMed ID: 29743397
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy.
Chang A; Kowalewska J; Smith KD; Nicosia RF; Alpers CE
Clin Nephrol; 2006 Dec; 66(6):397-404. PubMed ID: 17176910
[TBL] [Abstract][Full Text] [Related]
18. Regorafenib-induced renal-limited thrombotic microangiopathy: a case report and review of literatures.
Yin Q; Guo N; Zhou X; Xu H; Lei S; Fu P; Zhong H
BMC Nephrol; 2022 Mar; 23(1):112. PubMed ID: 35305559
[TBL] [Abstract][Full Text] [Related]
19. Plasma exchange for treatment of a therapy-related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma-A case report.
Stortz M; Shmanko K; Kraus D; Gairing S; Boedecker-Lips S; Förster F; Weinmann A; Weinmann-Menke J
Clin Case Rep; 2023 Nov; 11(11):e8124. PubMed ID: 37953891
[TBL] [Abstract][Full Text] [Related]
20. Renal Thrombotic Microangiopathy in Concurrent COVID-19 Vaccination and Infection.
De Fabritiis M; Angelini ML; Fabbrizio B; Cenacchi G; Americo C; Cristino S; Lifrieri MF; Cappuccilli M; Spazzoli A; Zambianchi L; Mosconi G
Pathogens; 2021 Aug; 10(8):. PubMed ID: 34451509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
